Results of fluorouracil-augmented Xen45 implantation in primary open-angle and pseudoexfoliation glaucoma.

Esin Fatma Başer Recep Goktug Seymenoglu

Published in: International ophthalmology (2020)

5-FU-augmented Xen45 implantation in POAG and PEXG patients provided safe and effective IOP lowering with significant reduction of glaucoma medications up to 3 years.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
high resolution
optic nerve
patient reported